Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
Clinical trial NCT05840510 · TERMINATED
Trial details
- NCT number
- NCT05840510
- Sponsor
- Mirati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-07
- Primary completion
- 2024-12-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.